Global Vials for COVID-19 Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Market Segment by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vials for COVID-19 Vaccine Market Size (2017-2028)
2.1.1 Global Vials for COVID-19 Vaccine Revenue (2017-2028)
2.1.2 Global Vials for COVID-19 Vaccine Sales (2017-2028)
2.2 Global Vials for COVID-19 Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Vials for COVID-19 Vaccine Sales by Regions (2017-2022)
2.2.2 Global Vials for COVID-19 Vaccine Revenue by Regions (2017-2022)
2.3 Global Vials for COVID-19 Vaccine Market Size Forecast by Region
2.3.1 Global Vials for COVID-19 Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Vials for COVID-19 Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Vials for COVID-19 Vaccine Regions (Countries) Ranking by Market Size
2.5 Vials for COVID-19 Vaccine Market Dynamics
2.5.1 Vials for COVID-19 Vaccine Market Trends
2.5.2 Vials for COVID-19 Vaccine Market Drivers
2.5.3 Vials for COVID-19 Vaccine Market Challenges
2.5.4 Vials for COVID-19 Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Vials for COVID-19 Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Vials for COVID-19 Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Vials for COVID-19 Vaccine Sales in 2021
3.2 Global Top Manufacturers Vials for COVID-19 Vaccine by Revenue
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Vials for COVID-19 Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Vials for COVID-19 Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vials for COVID-19 Vaccine as of 2021)
3.4 Global Vials for COVID-19 Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vials for COVID-19 Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vials for COVID-19 Vaccine Market
3.7 Key Manufacturers Vials for COVID-19 Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vials for COVID-19 Vaccine Market Size by Type
4.1 Global Vials for COVID-19 Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Vials for COVID-19 Vaccine Price by Type (2017-2022)
4.2 Global Vials for COVID-19 Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Vials for COVID-19 Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Vials for COVID-19 Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Vials for COVID-19 Vaccine Price Forecast by Type (2023-2028)
5 Global Vials for COVID-19 Vaccine Market Size by Application
5.1 Global Vials for COVID-19 Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Vials for COVID-19 Vaccine Price by Application (2017-2022)
5.2 Global Vials for COVID-19 Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Vials for COVID-19 Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Vials for COVID-19 Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Vials for COVID-19 Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vials for COVID-19 Vaccine Sales Breakdown by Company
6.1.1 North America Vials for COVID-19 Vaccine Sales by Company (2017-2022)
6.1.2 North America Vials for COVID-19 Vaccine Revenue by Company (2017-2022)
6.2 North America Vials for COVID-19 Vaccine Market Size by Type
6.2.1 North America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
6.2.2 North America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
6.3 North America Vials for COVID-19 Vaccine Market Size by Application
6.3.1 North America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
6.3.2 North America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
6.4 North America Vials for COVID-19 Vaccine Market Size by Country
6.4.1 North America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
6.4.2 North America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vials for COVID-19 Vaccine Sales Breakdown by Company
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Company (2017-2022)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Company (2017-2022)
7.2 Europe Vials for COVID-19 Vaccine Market Size by Type
7.2.1 Europe Vials for COVID-19 Vaccine Sales by Type (2017-2028)
7.2.2 Europe Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
7.3 Europe Vials for COVID-19 Vaccine Market Size by Application
7.3.1 Europe Vials for COVID-19 Vaccine Sales by Application (2017-2028)
7.3.2 Europe Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
7.4 Europe Vials for COVID-19 Vaccine Market Size by Country
7.4.1 Europe Vials for COVID-19 Vaccine Sales by Country (2017-2028)
7.4.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vials for COVID-19 Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Vials for COVID-19 Vaccine Market Size by Type
8.2.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Vials for COVID-19 Vaccine Market Size by Application
8.3.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Vials for COVID-19 Vaccine Market Size by Region
8.4.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Region
8.4.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Vials for COVID-19 Vaccine Sales Breakdown by Company
9.1.1 Latin America Vials for COVID-19 Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Vials for COVID-19 Vaccine Revenue by Company (2017-2022)
9.2 Latin America Vials for COVID-19 Vaccine Market Size by Type
9.2.1 Latin America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
9.3 Latin America Vials for COVID-19 Vaccine Market Size by Application
9.3.1 Latin America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
9.4 Latin America Vials for COVID-19 Vaccine Market Size by Country
9.4.1 Latin America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vials for COVID-19 Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Type
10.2.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Application
10.3.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Country
10.4.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Corning
11.1.1 Corning Corporation Information
11.1.2 Corning Overview
11.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Corning Vials for COVID-19 Vaccine Products and Services
11.1.5 Corning Vials for COVID-19 Vaccine SWOT Analysis
11.1.6 Corning Recent Developments
11.2 Schott AG
11.2.1 Schott AG Corporation Information
11.2.2 Schott AG Overview
11.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Schott AG Vials for COVID-19 Vaccine Products and Services
11.2.5 Schott AG Vials for COVID-19 Vaccine SWOT Analysis
11.2.6 Schott AG Recent Developments
11.3 SiO2 Materials Science
11.3.1 SiO2 Materials Science Corporation Information
11.3.2 SiO2 Materials Science Overview
11.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Products and Services
11.3.5 SiO2 Materials Science Vials for COVID-19 Vaccine SWOT Analysis
11.3.6 SiO2 Materials Science Recent Developments
11.4 SGD Pharma
11.4.1 SGD Pharma Corporation Information
11.4.2 SGD Pharma Overview
11.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 SGD Pharma Vials for COVID-19 Vaccine Products and Services
11.4.5 SGD Pharma Vials for COVID-19 Vaccine SWOT Analysis
11.4.6 SGD Pharma Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Corporation Information
11.5.2 Stevanato Group Overview
11.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Stevanato Group Vials for COVID-19 Vaccine Products and Services
11.5.5 Stevanato Group Vials for COVID-19 Vaccine SWOT Analysis
11.5.6 Stevanato Group Recent Developments
11.6 DWK Life Sciences
11.6.1 DWK Life Sciences Corporation Information
11.6.2 DWK Life Sciences Overview
11.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Products and Services
11.6.5 DWK Life Sciences Vials for COVID-19 Vaccine SWOT Analysis
11.6.6 DWK Life Sciences Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Gerresheimer Vials for COVID-19 Vaccine Products and Services
11.7.5 Gerresheimer Vials for COVID-19 Vaccine SWOT Analysis
11.7.6 Gerresheimer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vials for COVID-19 Vaccine Value Chain Analysis
12.2 Vials for COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vials for COVID-19 Vaccine Production Mode & Process
12.4 Vials for COVID-19 Vaccine Sales and Marketing
12.4.1 Vials for COVID-19 Vaccine Sales Channels
12.4.2 Vials for COVID-19 Vaccine Distributors
12.5 Vials for COVID-19 Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Middle-borate Borosilicate Glass
Table 3. Major Manufacturers of Low-borate Borosilicate Glass
Table 4. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vials for COVID-19 Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Vials for COVID-19 Vaccine Sales by Region (2017-2022) & (Million Units)
Table 7. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Vials for COVID-19 Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2017-2022)
Table 10. Global Vials for COVID-19 Vaccine Sales Forecast by Region (2023-2028) & (Million Units)
Table 11. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Vials for COVID-19 Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Vials for COVID-19 Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Vials for COVID-19 Vaccine Market Trends
Table 16. Vials for COVID-19 Vaccine Market Drivers
Table 17. Vials for COVID-19 Vaccine Market Challenges
Table 18. Vials for COVID-19 Vaccine Market Restraints
Table 19. Global Vials for COVID-19 Vaccine Sales by Manufacturers (2017-2022) & (Million Units)
Table 20. Global Vials for COVID-19 Vaccine Sales Share by Manufacturers (2017-2022)
Table 21. Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Vials for COVID-19 Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 23. Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2017-2022)
Table 24. Global Vials for COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vials for COVID-19 Vaccine as of 2021)
Table 26. Key Manufacturers Vials for COVID-19 Vaccine Average Selling Price (ASP) & (2017-2022) & (US$/K Units)
Table 27. Key Manufacturers Vials for COVID-19 Vaccine Plants/Factories Distribution
Table 28. Key Manufacturers Vials for COVID-19 Vaccine Area Served
Table 29. Date of Key Manufacturers Enter into Vials for COVID-19 Vaccine Market
Table 30. Key Manufacturers Vials for COVID-19 Vaccine Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Vials for COVID-19 Vaccine Sales (Million Units) by Type (2017-2022)
Table 33. Global Vials for COVID-19 Vaccine Sales Share by Type (2017-2022)
Table 34. Global Vials for COVID-19 Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Vials for COVID-19 Vaccine Price (Million Units) by Type (2017-2022)
Table 36. Global Vials for COVID-19 Vaccine Sales (Million Units) by Type (2023-2028)
Table 37. Global Vials for COVID-19 Vaccine Sales Share by Type (2023-2028)
Table 38. Global Vials for COVID-19 Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Vials for COVID-19 Vaccine Revenue Share by Type (2023-2028)
Table 40. Global Vials for COVID-19 Vaccine Price (Million Units) by Type (2023-2028)
Table 41. Global Vials for COVID-19 Vaccine Sales (Million Units) by Application (2017-2022)
Table 42. Global Vials for COVID-19 Vaccine Sales Share by Application (2017-2022)
Table 43. Global Vials for COVID-19 Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Vials for COVID-19 Vaccine Price (Million Units) by Application (2017-2022)
Table 45. Global Vials for COVID-19 Vaccine Sales (Million Units) by Application (2023-2028)
Table 46. Global Vials for COVID-19 Vaccine Sales Share by Application (2023-2028)
Table 47. Global Vials for COVID-19 Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Vials for COVID-19 Vaccine Revenue Share by Application (2023-2028)
Table 49. Global Vials for COVID-19 Vaccine Price (Million Units) by Application (2023-2028)
Table 50. North America Vials for COVID-19 Vaccine Sales by Company (2017-2022) & (Million Units)
Table 51. North America Vials for COVID-19 Vaccine Sales Market Share by Company (2017-2022)
Table 52. North America Vials for COVID-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Vials for COVID-19 Vaccine Revenue Market Share by Company (2017-2022)
Table 54. North America Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 55. North America Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 56. North America Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 59. North America Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 60. North America Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 63. North America Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 64. North America Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Vials for COVID-19 Vaccine Sales by Company (2017-2022) & (Million Units)
Table 67. Europe Vials for COVID-19 Vaccine Sales Market Share by Company (2017-2022)
Table 68. Europe Vials for COVID-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Vials for COVID-19 Vaccine Revenue Market Share by Company (2017-2022)
Table 70. Europe Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 71. Europe Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 72. Europe Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 75. Europe Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 76. Europe Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 79. Europe Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 80. Europe Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Vials for COVID-19 Vaccine Sales by Company (2017-2022) & (Million Units)
Table 83. Asia Pacific Vials for COVID-19 Vaccine Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Vials for COVID-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Vials for COVID-19 Vaccine Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 87. Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 88. Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 91. Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 92. Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2017-2022) & (Million Units)
Table 95. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2023-2028) & (Million Units)
Table 96. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Vials for COVID-19 Vaccine Sales by Company (2017-2022) & (Million Units)
Table 99. Latin America Vials for COVID-19 Vaccine Sales Market Share by Company (2017-2022)
Table 100. Latin America Vials for COVID-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Vials for COVID-19 Vaccine Revenue Market Share by Company (2017-2022)
Table 102. Latin America Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 103. Latin America Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 104. Latin America Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 107. Latin America Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 108. Latin America Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 111. Latin America Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 112. Latin America Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Vials for COVID-19 Vaccine Sales by Company (2017-2022) & (Million Units)
Table 115. Middle East and Africa Vials for COVID-19 Vaccine Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Vials for COVID-19 Vaccine Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 119. Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 120. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 123. Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 124. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 127. Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 128. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 130. Corning Corporation Information
Table 131. Corning Description and Overview
Table 132. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 133. Corning Vials for COVID-19 Vaccine Product and Services
Table 134. Corning Vials for COVID-19 Vaccine SWOT Analysis
Table 135. Corning Recent Developments
Table 136. Schott AG Corporation Information
Table 137. Schott AG Description and Overview
Table 138. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 139. Schott AG Vials for COVID-19 Vaccine Product and Services
Table 140. Schott AG Vials for COVID-19 Vaccine SWOT Analysis
Table 141. Schott AG Recent Developments
Table 142. SiO2 Materials Science Corporation Information
Table 143. SiO2 Materials Science Description and Overview
Table 144. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 145. SiO2 Materials Science Vials for COVID-19 Vaccine Product and Services
Table 146. SiO2 Materials Science Vials for COVID-19 Vaccine SWOT Analysis
Table 147. SiO2 Materials Science Recent Developments
Table 148. SGD Pharma Corporation Information
Table 149. SGD Pharma Description and Overview
Table 150. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 151. SGD Pharma Vials for COVID-19 Vaccine Product and Services
Table 152. SGD Pharma Vials for COVID-19 Vaccine SWOT Analysis
Table 153. SGD Pharma Recent Developments
Table 154. Stevanato Group Corporation Information
Table 155. Stevanato Group Description and Overview
Table 156. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 157. Stevanato Group Vials for COVID-19 Vaccine Product and Services
Table 158. Stevanato Group Vials for COVID-19 Vaccine SWOT Analysis
Table 159. Stevanato Group Recent Developments
Table 160. DWK Life Sciences Corporation Information
Table 161. DWK Life Sciences Description and Overview
Table 162. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 163. DWK Life Sciences Vials for COVID-19 Vaccine Product and Services
Table 164. DWK Life Sciences Vials for COVID-19 Vaccine SWOT Analysis
Table 165. DWK Life Sciences Recent Developments
Table 166. Gerresheimer Corporation Information
Table 167. Gerresheimer Description and Overview
Table 168. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2017-2022)
Table 169. Gerresheimer Vials for COVID-19 Vaccine Product and Services
Table 170. Gerresheimer Vials for COVID-19 Vaccine SWOT Analysis
Table 171. Gerresheimer Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Vials for COVID-19 Vaccine Distributors List
Table 175. Vials for COVID-19 Vaccine Customers List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of FiguresFigure 1. Vials for COVID-19 Vaccine Product Picture
Figure 2. Global Vials for COVID-19 Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Middle-borate Borosilicate Glass Product Picture
Figure 4. Low-borate Borosilicate Glass Product Picture
Figure 5. Global Vials for COVID-19 Vaccine Sales Market Share by Application in 2021 & 2028
Figure 6. Vaccine Manufacturing Use Case
Figure 7. Vaccine Researching Use Case
Figure 8. Vials for COVID-19 Vaccine Report Years Considered
Figure 9. Global Vials for COVID-19 Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Vials for COVID-19 Vaccine Market Size 2017-2028 (US$ Million)
Figure 11. Global Vials for COVID-19 Vaccine Sales (2017-2022) & (Million Units)
Figure 12. Global Vials for COVID-19 Vaccine Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Vials for COVID-19 Vaccine Sales Market Share by Region in 2021
Figure 15. Global Vials for COVID-19 Vaccine Revenue Market Share by Region in 2017 VS 2021
Figure 16. Global Vials for COVID-19 Vaccine Sales Share by Manufacturers in 2021
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Vials for COVID-19 Vaccine Sales in 2021
Figure 18. Vials for COVID-19 Vaccine Revenue Share by Manufacturers in 2021
Figure 19. Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Vials for COVID-19 Vaccine Revenue Share by Type (2017-2022)
Figure 21. Global Vials for COVID-19 Vaccine Revenue Growth Rate by Type in 2017 & 2021
Figure 22. Global Vials for COVID-19 Vaccine Revenue Share by Application (2017-2022)
Figure 23. Global Vials for COVID-19 Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 24. North America Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 25. North America Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 26. North America Vials for COVID-19 Vaccine